Gassen William 4
4 · Oscar Health, Inc. · Filed Jun 8, 2026
Research Summary
AI-generated summary of this filing
Oscar Health Director William Gassen Receives 8,475 RSU Award
What Happened
- William Gassen, a director of Oscar Health, Inc. (OSCR), received a grant of 8,475 restricted stock units (RSUs) on June 4, 2026. The reported acquisition price is $0.00 (code A — award/grant), so no cash was exchanged.
Key Details
- Transaction date: 2026-06-04; Form 4 filed: 2026-06-08 (timely filing).
- Amount: 8,475 RSUs; reported acquisition price: $0.00.
- Shares owned after transaction: Not reported in the filing.
- Footnote summary: These are RSUs that vest on the earlier of (i) one year after the grant and (ii) the next annual meeting, subject to continued service. Vested RSUs will be settled in Class A common stock upon certain events (e.g., six months after separation, death or disability, or within five days following a change in control).
- Transaction code: A = Award/Grant.
Context
- This is an equity award to a director, not an open-market purchase or sale—common for compensation or retention. RSUs are a contingent right to receive shares under the vesting and settlement terms above, so they do not immediately increase tradable shares outstanding for the insider until settlement.
Insider Transaction Report
Form 4
Gassen William
Director
Transactions
- Award
Class A Common Stock
[F1]2026-06-04+8,475→ 82,840 total
Footnotes (1)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Oscar Health, Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date. To the extent vested, the RSUs will be settled in shares of the Issuer's Class A common stock on the earliest of (i) the six-month anniversary of the director's separation from service, death or disability and (ii) within five days following a change in control of the Issuer.
Signature
/s/ Melissa Curtin, Attorney-in-Fact|2026-06-08